460 related articles for article (PubMed ID: 22247020)
1. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
2. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract][Full Text] [Related]
3. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
Wang X; Osada T; Wang Y; Yu L; Sakakura K; Katayama A; McCarthy JB; Brufsky A; Chivukula M; Khoury T; Hsu DS; Barry WT; Lyerly HK; Clay TM; Ferrone S
J Natl Cancer Inst; 2010 Oct; 102(19):1496-512. PubMed ID: 20852124
[TBL] [Abstract][Full Text] [Related]
4. Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.
Zhou F; Li M; Wei Y; Lin K; Lu Y; Shen J; Johanning GL; Wang-Johanning F
Oncotarget; 2016 Dec; 7(51):84093-84117. PubMed ID: 27557521
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.
Zhou F; Krishnamurthy J; Wei Y; Li M; Hunt K; Johanning GL; Cooper LJ; Wang-Johanning F
Oncoimmunology; 2015 Nov; 4(11):e1047582. PubMed ID: 26451325
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral
Li M; Radvanyi L; Yin B; Rycaj K; Li J; Chivukula R; Lin K; Lu Y; Shen J; Chang DZ; Li D; Johanning GL; Wang-Johanning F
Clin Cancer Res; 2017 Oct; 23(19):5892-5911. PubMed ID: 28679769
[No Abstract] [Full Text] [Related]
7. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes.
Jain R; Rawat A; Verma B; Markiewski MM; Weidanz JA
J Natl Cancer Inst; 2013 Feb; 105(3):202-18. PubMed ID: 23300219
[TBL] [Abstract][Full Text] [Related]
9. Human endogenous retroviruses and cancer prevention: evidence and prospects.
Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
[TBL] [Abstract][Full Text] [Related]
10. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.
Wang-Johanning F; Radvanyi L; Rycaj K; Plummer JB; Yan P; Sastry KJ; Piyathilake CJ; Hunt KK; Johanning GL
Cancer Res; 2008 Jul; 68(14):5869-77. PubMed ID: 18632641
[TBL] [Abstract][Full Text] [Related]
11. Expression of human endogenous retrovirus env genes in the blood of breast cancer patients.
Rhyu DW; Kang YJ; Ock MS; Eo JW; Choi YH; Kim WJ; Leem SH; Yi JM; Kim HS; Cha HJ
Int J Mol Sci; 2014 May; 15(6):9173-83. PubMed ID: 24964007
[TBL] [Abstract][Full Text] [Related]
12. Analysis of KAP1 expression patterns and human endogenous retrovirus Env proteins in ovarian cancer.
Jeon KY; Ko EJ; Oh YL; Kim H; Eo WK; Kim A; Sun HG; Ock MS; Kim KH; Cha HJ
Genes Genomics; 2020 Oct; 42(10):1145-1150. PubMed ID: 32785870
[TBL] [Abstract][Full Text] [Related]
13. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.
Johanning GL; Malouf GG; Zheng X; Esteva FJ; Weinstein JN; Wang-Johanning F; Su X
Sci Rep; 2017 Feb; 7():41960. PubMed ID: 28165048
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
15. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of HERV-K env gene expression and splicing in human breast cancer.
Wang-Johanning F; Frost AR; Jian B; Epp L; Lu DW; Johanning GL
Oncogene; 2003 Mar; 22(10):1528-35. PubMed ID: 12629516
[TBL] [Abstract][Full Text] [Related]
17. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.
Golan M; Hizi A; Resau JH; Yaal-Hahoshen N; Reichman H; Keydar I; Tsarfaty I
Neoplasia; 2008 Jun; 10(6):521-33. PubMed ID: 18516289
[TBL] [Abstract][Full Text] [Related]
18. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.
Bhat RK; Rudnick W; Antony JM; Maingat F; Ellestad KK; Wheatley BM; Tönjes RR; Power C
PLoS One; 2014; 9(7):e97984. PubMed ID: 24988390
[TBL] [Abstract][Full Text] [Related]
19. HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer.
Rezaei SD; Hayward JA; Norden S; Pedersen J; Mills J; Hearps AC; Tachedjian G
Viruses; 2021 Mar; 13(3):. PubMed ID: 33802118
[TBL] [Abstract][Full Text] [Related]
20. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL
Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
